| KOTAK MNC FUND
An open-ended equity scheme following Multi-national Companies (MNC) theme
| KOTAK MNC FUND
An open-ended equity scheme following Multi-national Companies (MNC) theme

  

  
Investment Objective

The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.

The investment objective of the scheme is to generate long-term capital appreciation from a portfolio that is invested predominantly in equity and equity related securities of multi-national companies (MNC). However, there is no assurance that the objective of the scheme will be achieved.

Issuer/Instrument
% to Net
Assets

Equity & Equity related
Pharmaceuticals and Biotechnology 12.95
JB CHEMICALS & PHARMACEUTICALS LTD. 2.77
Sun Pharmaceuticals Industries Ltd. 2.52
Marksans Pharma Ltd 2.03
Glenmark Pharmaceuticals Ltd 1.84
JUBILANT PHARMOVA LIMITED 1.51
AMI ORGANICS LTD 1.05
ORCHID PHARMA LTD. 0.69
SAI LIFE SCIENCES LIMITED 0.54
Food Products 10.30
Britannia Industries Ltd. 6.51
NESTLE INDIA LTD. 3.79
IT - Software 9.34
Oracle Financial Services Software Ltd 2.89
Tech Mahindra Ltd. 2.58
Infosys Ltd. 2.23
Mphasis Ltd 1.64
Automobiles 8.81
Maruti Suzuki India Limited 8.81
Diversified FMCG 8.01
Hindustan Unilever Ltd. 8.01
Electrical Equipment 7.58
AZAD ENGINEERING LTD 2.48
ABB India Ltd 1.89
Siemens Ltd. 1.66
GE VERNOVA T&D INDIA LIMITED 1.55
Auto Components 5.83
Schaeffler India Ltd 1.90
Bosch Ltd. 1.27
ZF Commercial Vehicle Control Systems India Limited 1.18
SAMVARDHANA MOTHERSON INTERNATIONAL LIMITED 0.80
SONA BLW PRECISION FORGINGS LTD 0.68
Industrial Products 5.28
Timken India Ltd. 1.52
Cummins India Ltd. 1.50
Grindwell Norton Ltd. 1.43
KSB LTD 0.83
Beverages 4.44
UNITED SPIRITS LTD. 4.44
Healthcare Services 3.40
ASTER DM HEALTHCARE LTD 1.80
Fortis Healthcare India Ltd 1.60
Telecom - Services 3.03
Bharti Airtel Ltd 3.03
Chemicals and Petrochemicals 2.11
Tata Chemicals Ltd 2.11
Retailing 1.97
SWIGGY LTD 1.97
Agricultural, Commercial and Construction Vehicles 1.90
Ashok Leyland Ltd. 1.90
Capital Markets 1.82
Nippon Life India Asset Management Ltd. 1.82
Power 1.42
SIEMENS ENERGY INDIA LTD 1.42
Personal Products 1.38
Colgate Palmolive (India ) Ltd. 1.38
Finance 1.25
CRISIL Ltd. 1.25
Aerospace and Defense 1.15
MTAR Technologies Ltd. 1.15
Industrial Manufacturing 1.13
Tega Industries Ltd. 1.13
Leisure Services 0.20
JUNIPER HOTELS LIMITED 0.20
Equity & Equity related - Total 93.30
Triparty Repo 6.86
Net Current Assets/(Liabilities) -0.16
Grand Total 100.00



Systematic Investment Plan (SIP) If you had invested Rs 10,000 every month
Monthly SIP of Rs 10000 Since Inception 6 months
Total amount invested (Rs) 70,000 60,000
Total Value as on Apr 30, 2025 (Rs) 67,726 58,423
Scheme Returns (%) -10.02 -9.03
Nifty MNC Index Returns (%) -5.29 -2.73
Alpha* -4.73 -6.31
Nifty MNC Index (TRI) (Rs)# 68,818 59,534
Nifty 50 (TRI) (Rs)^ 72,477 62,439
Nifty 50 (TRI) Returns (%) 11.66 15.09

Scheme Inception : - March 04, 2024. The returns are calculated by XIRR approach assuming investment of ₹10,000/- on the 1st working day of every month. XIRR helps in calculating return on investments given an initial and final value and a series of cash inflows and outflows and taking the time of investment into consideration. Since inception returns are assumed to be starting from the beginning of the subsequent month from the date of inception. The SIP Performance is for Regular Plan – Growth Option Different plans have different expense structure. # Benchmark; ^ Additional Benchmark. TRI – Total Return Index, In terms of para 6.14 of SEBI Master circular No. SEBI/HO/IMD/IMD-PoD-1/P/CIR/2024/90 dated June 27, 2024, the performance of the scheme is benchmarked to the Total Return variant (TRI) of the Benchmark Index instead of Price Return Variant (PRI). Alpha is difference of scheme return with benchmark return. *All payouts during the period have been reinvested in the units of the scheme at the then prevailing NAV. Source: ICRA MFI Explorer.
Net Asset Value (NAV)
RegularDirect
Growth Rs9.3030Rs9.3720
IDCW Rs9.3030Rs9.3730
(as on April 30, 2025)

Available Plans/Options

A) Regular Plan B) Direct Plan
Options: Growth and Income Distribution cum capital withdrawal (IDCW) (Payout and Reinvestment)


Fund Manager* Mr. Harsha Upadhyaya,
Mr. Dhananjay Tikariha &
Mr. Abhishek Bisen
BenchmarkNifty MNC Index TRI
Allotment dateOctober 28, 2024
AAUMRs2,096.56 crs
AUMRs2,157.23 crs
Folio count1,22,761

IDCW Frequency

Trustee's Discretion


Ratios
$Beta1.07
$Sharpe ##-0.66
$Standard Deviation19.66%
^^(P/E) 51.64
^^P/BV 6.34
Source: ^^Bloomberg

Minimum Investment Amount

Initial & Additional Investment
Rs100 and any amount thereafter
Systematic Investment Plan (SIP)
Rs 100 and any amount thereafter

Ideal Investments Horizon

• 5 years & above


Load Structure

Entry Load: Nil. (applicable for all plans)
Exit Load:
• For redemption / switch out within 90 days from the date of allotment: 0.5%
• If units are redeemed or switched out on or after 90 days from the date of allotment - Nil


Total Expense Ratio**
Regular Plan: 2.00%
Direct Plan: 0.56%

Data as on 30th April, 2025 unless otherwise specified.

Folio Count data as on 31st March 2025.

Fund


Benchmark : Nifty MNC Index TRI
This product is suitable for investors who are seeking*:
  • Long-term capital growth
  • Investment in portfolio of predominantly in equity and equity related securities of multi-national companies (MNC).

* Investors should consult their financial advisors if in doubt about whether the product is suitable for them.

For latest Riskometer, investors may refer to an addendum issued or updated on website at www.kotakmf.com

**Total Expense Ratio includes applicable B30 fee and GST.
Scheme has not completed 6 months since inception
* For Fund Manager experience, please refer 'For Regular Plan' & 'For Direct Plan'